BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Pellicelli AM, Marignani M, Zoli V, Romano M, Morrone A, Nosotti L, Barbaro G, Picardi A, Gentilucci UV, Remotti D, D'Ambrosio C, Furlan C, Mecenate F, Mazzoni E, Majolino I, Villani R, Andreoli A, Barbarini G. Hepatitis C virus-related B cell subtypes in non Hodgkin's lymphoma. World J Hepatol 2011; 3(11): 278-284 [PMID: 22125661 DOI: 10.4254/wjh.v3.i11.278]
URL: https://www.wjgnet.com/1948-5182/full/v3/i11/278.htm
Number Citing Articles
1
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2016; : 1 doi: 10.1007/978-3-319-26587-2_91-1
2
Adriano M. Pellicelli, Cecilia D’Ambrosio, Maria L. Dessanti, Roberto Villani, Lucia Fondacaro, Lucia Miglioresi, Lucia R. Grillo, Arnaldo Andreoli. Cholestatic hepatitis C after chemotherapy containing rituximab in diffuse large B cell lymphomaAnnals of Hepatology 2015; 14(5): 756 doi: 10.1016/S1665-2681(19)30773-2
3
Sirio Fiorino, Letizia Bacchi-Reggiani, Dario de Biase, Adele Fornelli, Michele Masetti, Andrea Tura, Fabio Grizzi, Matteo Zanello, Laura Mastrangelo, Raffaele Lombardi, Giorgia Acquaviva, Luca di Tommaso, Arrigo Bondi, Michela Visani, Sergio Sabbatani, Laura Pontoriero, Carlo Fabbri, Andrea Cuppini, Annalisa Pession, Elio Jovine. Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic reviewWorld Journal of Gastroenterology 2015; 21(45): 12896-12953 doi: 10.3748/wjg.v21.i45.12896
4
Carlo Visco, Silvia Finotto. Hepatitis C virus and diffuse large B-cell lymphoma: Pathogenesis, behavior and treatmentWorld Journal of Gastroenterology 2014; 20(32): 11054-11061 doi: 10.3748/wjg.v20.i32.11054
5
Semra Paydas. Hepatitis C virus and lymphomaCritical Reviews in Oncology/Hematology 2015; 93(3): 246 doi: 10.1016/j.critrevonc.2014.10.008
6
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2017; : 1671 doi: 10.1007/978-3-319-26956-6_94
7
Gabriele Pozzato, Cesare Mazzaro, Luigino Dal Maso, Endri Mauro, Francesca Zorat, Giulia Moratelli, Pietro Bulian, Diego Serraino, Valter Gattei. Hepatitis C virus and non-Hodgkin’s lymphomas: Meta-analysis of epidemiology data and therapy optionsWorld Journal of Hepatology 2016; 8(2): 107-116 doi: 10.4254/wjh.v8.i2.107
8
A. Schiavinato, A. Zanetto, G. Pantano, F. Tosato, M. Nabergoj, P. Fogar, E. Piva, M. Gambato, E. Franceschet, A. Floreani, F. Farinati, P. Burra, F. P. Russo, M. Plebani. Polyclonal and monoclonal B lymphocytes response in HCV-infected patients treated with direct-acting antiviral agentsJournal of Viral Hepatitis 2017; 24(12): 1168 doi: 10.1111/jvh.12746
9
Gian Paolo Caviglia, Claudio Sciacca, Maria Lorena Abate, Antonella Olivero, Chiara Rosso, Giovanni Antonio Touscoz, Alessia Ciancio, Mario Rizzetto, Antonina Smedile. Chronic hepatitis C virus infection and lymphoproliferative disorders: Mixed cryoglobulinemia syndrome, monoclonal gammopathy of undetermined significance, and B-cell non-Hodgkin lymphomaJournal of Gastroenterology and Hepatology 2015; 30(4): 742 doi: 10.1111/jgh.12837
10
Anna Linda Zignego, Laura Gragnani, Alessia Piluso, Marco Sebastiani, Dilia Giuggioli, Poupak Fallahi, Alessandro Antonelli, Clodoveo Ferri. Virus-driven autoimmunity and lymphoproliferation: the example of HCV infectionExpert Review of Clinical Immunology 2015; 11(1): 15 doi: 10.1586/1744666X.2015.997214
11
Ling Zhang, Roger Klein. Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics2012; : 157 doi: 10.1007/978-94-007-5028-9_9
12
Michele Merli, Sara Rattotti, Manuel Gotti, Luca Arcaini. Antiviral therapies for managing viral hepatitis in lymphoma patientsExpert Opinion on Pharmacotherapy 2017; 18(4): 363 doi: 10.1080/14656566.2017.1288718
13
Michele Merli, Giuseppe Carli, Luca Arcaini, Carlo Visco. Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphomaWorld Journal of Gastroenterology 2016; 22(38): 8447-8458 doi: 10.3748/wjg.v22.i38.8447
14
Alfredo Marzano, Emanuele Angelucci, Marco Astegiano, Chiara Baratelli, Luigi Biancone, Paolo Bironzo, Giuseppina Brancaccio, Maurizia Rossana Brunetto, Raffaele Bruno, Patrizia Burra, Maria Giuseppina Cabras, Paolo Caraceni, Claudia Chialà, Maria Grazia Clemente, Agostino Colli, Bruno Daniele, Elisabetta De Gasperi, Vito Di Marco, Maria Chiara Ditto, Stefano Fagiuoli, Clodoveo Ferri, Giovanni Battista Gaeta, Paolo Antonio Grossi, Barbara Imperatrice, Pietro Lampertico, Fabio Salvatore Macaluso, Salvatore Madonia, Massimo Marignani, Chiara Mazzarelli, Alberto Mella, Gabriele Missale, Simone Parisi, Luisa Pasulo, Massimo Puoti, Maria Rendina, Davide Ribaldone, Giuseppe Rossi, Pierluigi Toniutto, Alessandra Tucci, Pietro Vajro, Mauro Viganò, Riccardo Volpes, Anna Linda Zignego. AISF position paper on HCV in immunocompromised patientsDigestive and Liver Disease 2019; 51(1): 10 doi: 10.1016/j.dld.2018.09.022
15
Elisabetta Degasperi, Alessio Aghemo, Massimo Colombo. Treatment of Extrahepatic Manifestations of Hepatitis C VirusClinics in Liver Disease 2017; 21(3): 631 doi: 10.1016/j.cld.2017.03.015
16
Fabio Forghieri, Mario Luppi, Patrizia Barozzi, Rossana Maffei, Leonardo Potenza, Franco Narni, Roberto Marasca. Pathogenetic Mechanisms of Hepatitis C Virus-Induced B-Cell LymphomagenesisClinical and Developmental Immunology 2012; 2012: 1 doi: 10.1155/2012/807351
17
Barbara Vannata, Luca Arcaini, Emanuele Zucca. Hepatitis C virus-associated B-cell non-Hodgkin’s lymphomas: what do we know?Therapeutic Advances in Hematology 2016; 7(2): 94 doi: 10.1177/2040620715623924
18
Ivan Dlouhy, Miguel Á. Torrente, Sabela Lens, Jordina Rovira, Laura Magnano, Eva Giné, Julio Delgado, Olga Balagué, Antonio Martínez, Elías Campo, Xavier Forns, José M. Sánchez-Tapias, Armando López-Guillermo. Clinico-biological characteristics and outcome of hepatitis C virus-positive patients with diffuse large B-cell lymphoma treated with immunochemotherapyAnnals of Hematology 2017; 96(3): 405 doi: 10.1007/s00277-016-2903-8
19
Marcella Visentini, Massimo Fiorilli, Milvia Casato. From the pathogenesis to the cure of indolent B-cell lymphoproliferative disorders associated with hepatitis C virus infection: which role for direct-acting antivirals?Expert Review of Hematology 2017; 10(8): 719 doi: 10.1080/17474086.2017.1349607
20
Michiel van den Brand, Blanca Scheijen, Corine J. Hess, J. Han JM van Krieken, Patricia J.T.A. Groenen. Pathways towards indolent B-cell lymphoma — Etiology and therapeutic strategiesBlood Reviews 2017; 31(6): 426 doi: 10.1016/j.blre.2017.08.002
21
Giovanni Galati, Lorenzo Rampa, Umberto Vespasiani-Gentilucci, Mirella Marino, Francesco Pisani, Carlo Cota, Alessandro Guidi, Antonio Picardi. Hepatitis C and double-hit B cell lymphoma successfully treated by antiviral therapyWorld Journal of Hepatology 2016; 8(29): 1244-1250 doi: 10.4254/wjh.v8.i29.1244
22
HIROKI NISHIKAWA, MITSURU TSUDO, YUKIO OSAKI. Clinical outcome in diffuse large B-cell lymphoma with hepatitis C virus infection in the rituximab era: A single center experienceOncology Reports 2012; 28(3): 835 doi: 10.3892/or.2012.1883
23
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2017; : 1617 doi: 10.1007/978-3-319-26956-6_91
24
Barbara Vannata, Emanuele Zucca. Hepatitis C virus-associated B-cell non-Hodgkin lymphomasHematology 2014; 2014(1): 590 doi: 10.1182/asheducation-2014.1.590
25
Hussein Khaled, Fouad Abu-Taleb, Rasha Haggag. Hepatitis C virus and non-Hodgkin’s lymphomas: A minireviewJournal of Advanced Research 2017; 8(2): 131 doi: 10.1016/j.jare.2016.11.005
26
S.M. Criscione. May viral (antigen) load be the real crucial tool leading to anergy in a “micro-evolutionary” model of host/virus interaction?Medical Hypotheses 2012; 79(6): 774 doi: 10.1016/j.mehy.2012.08.026
27
Mihály Sulyok, Mihály Makara, Eszter Újhelyi, István Vályi-Nagy. Non-Hodgkin Lymphoma and Hepatitis C: Where We are and What Next?Pathology & Oncology Research 2015; 21(1): 1 doi: 10.1007/s12253-014-9845-z
28
Albert Ndzengue, Lewis R. Roberts. Viruses and Human Cancer2014; : 51 doi: 10.1007/978-1-4939-0870-7_4
29
J. Peveling-Oberhag, L. Arcaini, K. Bankov, S. Zeuzem, E. Herrmann. The anti-lymphoma activity of antiviral therapy in HCV-associated B-cell non-Hodgkin lymphomas: a meta-analysisJournal of Viral Hepatitis 2016; 23(7): 536 doi: 10.1111/jvh.12518
30
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2016; : 1 doi: 10.1007/978-3-319-26587-2_94-1
31
Xiang Zhou, Katharina Lisenko, Nicola Lehners, Juliane Brandt, Martin Cremer, Mark Kriegsmann, Anthony Dick Ho, Mathias Witzens-Harig. HCV load as a possible prognostic factor in patients with HCV-related DLBCLAnnals of Hematology 2018; 97(2): 351 doi: 10.1007/s00277-017-3124-5
32
Jeff Hosry, Parag Mahale, Francesco Turturro, Roberto N. Miranda, Minas P. Economides, Bruno P. Granwehr, Harrys A. Torres. Antiviral therapy improves overall survival in hepatitis C virus-infected patients who develop diffuse large B-cell lymphomaInternational Journal of Cancer 2016; 139(11): 2519 doi: 10.1002/ijc.30372
33
L. Couronné, E. Bachy, S. Roulland, B. Nadel, F. Davi, M. Armand, D. Canioni, J.M. Michot, C. Visco, L. Arcaini, C. Besson, O. Hermine. From hepatitis C virus infection to B-cell lymphomaAnnals of Oncology 2018; 29(1): 92 doi: 10.1093/annonc/mdx635
34
Mario Masarone, Marcello Persico. Hepatitis C virus infection and non‐hepatocellular malignancies in the DAA era: A systematic review and meta‐analysisLiver International 2019; 39(7): 1292 doi: 10.1111/liv.14119
35
Jan Peveling-Oberhag, Luca Arcaini, Martin-Leo Hansmann, Stefan Zeuzem. Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical managementJournal of Hepatology 2013; 59(1): 169 doi: 10.1016/j.jhep.2013.03.018
36
Vincenzo Occhipinti, Lucia Farina, Mauro Viganò, Marco Capecchi, Sara Labanca, Ilaria Fanetti, Paolo Corradini, Mariagrazia Rumi. Concomitant therapy with direct-acting antivirals and chemoimmunotherapy in HCV-associated diffuse large B-cell lymphomaDigestive and Liver Disease 2019; 51(5): 719 doi: 10.1016/j.dld.2018.10.019